Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Ovarian Neoplasms 7 Lung Neoplasms 5 Central Nervous System Neoplasms 5 Retinoblastoma 4 Neuroblastoma 4 Uterine Cervical Neoplasms 3 Fallopian Tube Neoplasms 3 Breast Neoplasms 3 Testicular Neoplasms 2 Spinal Cord Neoplasms 2 Small Cell Lung Carcinoma 2 Oligodendroglioma 2 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Endometrial Neoplasms 2 Dendritic Cell Sarcoma, Interdigitating 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Waldenstrom Macroglobulinemia 1 Vomiting 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Stage IA Uterine Sarcoma 1 Solid Tumor Cancer 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1

Interventions

trifluridine tipiracil drug combination 1 tipiracil 1 Trifluridine 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Solid Tumor Cancer × Carboplatin × Clear all

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡